ResearcherUniversity of LiverpoolActive in the last 2 years

Sufyan Elhashani

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0001-8982-2315; OpenAlex author ID A5095911152. Sources: OpenAlex.

Their work

Papers: 1
Trials: 0
Grants: 0
Labs led: 0
Collaborators: 4

Papers, trials and grants by year

2024: 1 paper

Papers 1

Expression of versican isoforms V0/V1 by pancreatic cancer associated fibroblasts increases fibroblast proliferation. Co-author DOI 10.1016/j.pan.2024.04.008 ↗

Closest collaborators

The 4 strongest of 4 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

Michael C. Schmid · 1 shared paper, 2024 · strength 0.28
- Paper Expression of versican isoforms V0/V1 by pancreatic cancer associated fibroblasts increases fibroblast proliferation. DOI 10.1016/j.pan.2024.04.008 ↗
Ainhoa Mielgo Iza · 1 shared paper, 2024 · strength 0.28
- Paper Expression of versican isoforms V0/V1 by pancreatic cancer associated fibroblasts increases fibroblast proliferation. DOI 10.1016/j.pan.2024.04.008 ↗
Meirion Raymant Raymant · 1 shared paper, 2024 · strength 0.28
- Paper Expression of versican isoforms V0/V1 by pancreatic cancer associated fibroblasts increases fibroblast proliferation. DOI 10.1016/j.pan.2024.04.008 ↗
Mark A. Glenn · 1 shared paper, 2024 · strength 0.28
- Paper Expression of versican isoforms V0/V1 by pancreatic cancer associated fibroblasts increases fibroblast proliferation. DOI 10.1016/j.pan.2024.04.008 ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.